Early weight trends after congenital heart surgery and their determinants

Nayan Banerji1, Abish Sudhakar1, Rakhi Balachandran2

  • 1Department of Pediatric Cardiology, Amrita Institute of Medical Sciences and Research Center, Cochin, Kerala, India.

Cardiology in the Young
|December 27, 2019
PubMed

Insights

Infants often lose weight after congenital heart surgery, linked to longer nil-per-oral duration and complex procedures. However, most infants show significant weight gain after hospital discharge, independent of surgical factors.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Surgery
  • Global Health

Background:

  • Undernourished infants in low- and middle-income countries face undefined early weight trends post-cardiac surgery.
  • Congenital heart surgery in infants requires understanding post-operative weight dynamics.

Purpose of the Study:

  • To define early post-operative weight trends in infants undergoing congenital heart surgery.
  • To identify factors associated with early weight loss and poor post-discharge weight gain.

Main Methods:

  • Prospective observational study of 192 infants in Southern India.
  • Weight monitoring during hospitalization and at 1-month post-discharge.
  • Multivariate logistic regression analysis of pre-operative, operative, and post-operative variables.

Main Results:

  • A significant but small post-operative weight decline (1.6%) was observed.
  • Substantial weight gain (26.7%) occurred after discharge.
  • Post-operative weight loss correlated with nil-per-oral duration and cardiopulmonary bypass time; post-discharge gain correlated with age.

Conclusions:

  • Early post-operative weight loss is common after congenital heart surgery, associated with complex procedures and nil-per-oral duration.
  • Weight gain post-discharge is nearly universal and not linked to perioperative variables.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
232
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
6.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
621
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
211